Edouard De Dreuzy, et al. EDIT-301: An Experimental Autologous Cell Therapy Comprising Cas12a-RNP Modified mPB-CD34+ Cells for the Potential Treatment of SCD. Presented at the 61st Annual Meeting and Exposition of the American Society of Hematology (ASH). December 7-10, 2019.

Apr

22

Editas Medicine to Present Pre-clinical Data Demonstrating Progression of in vivo Medicines Pipeline at the American Society of Gene and Cell Therapy Annual Meeting

Feb

28

Editas Medicine Announces Fourth Quarter and Full Year 2023 Results and Business Updates

Feb

21

Editas Medicine Announces Fourth Quarter and Full Year 2023 Results Conference Call and Upcoming Investor Events